Click to view our statement on Accessibility

Suggested Searches

    Popular Searches

    Back
    Foley Viewpoints

    Product Distribution in the United States: A Common Market—or Balkanization?

    June 1, 2012

    Author(s)

    Michael J. Lockerby

    Washington, D.C. 202.945.6079

    Related Insights

    View All Posts
    July 23, 2025 Foley Viewpoints

    The One Big Beautiful Bill and Workplace Immigration Enforcement

    The “One Big Beautiful Bill Act,” signed into law by President Trump on July 4, 2025, will fund government efforts to continue to…
    July 23, 2025 Health Care Law Today

    Update: CMS Extends Skilled Nursing Facilities’ Medicare Revalidation Deadline

    On April 17, 2025, the Centers for Medicare and Medicaid Services (CMS) announced another extension of the deadline by which skilled nursing facilities (SNFs) must revalidate their Medicare enrollments.
    July 22, 2025 Health Care Law Today

    GLP-1 Receptor Agonists: Clinical Trial Considerations

    The U.S. Food & Drug Administration (FDA) has approved certain GLP-1 drugs for commercialization and use, including liraglutide (Victoza®), semaglutide (Ozempic®, Wegovy®), and tirzepatide (Mounjaro®, Zepbound®).